What is empty sella syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Empty Sella Syndrome?

Empty sella syndrome is a condition where cerebrospinal fluid herniates into the sella turcica through a deficient or absent sellar diaphragm, compressing and flattening the pituitary gland against the floor of the sella, which appears "empty" on imaging despite the pituitary gland still being present. 1

Pathophysiology and Classification

Empty sella occurs when the subarachnoid space herniates into the sella turcica, causing variable degrees of pituitary gland flattening. 2 The condition is classified into two distinct forms:

Primary Empty Sella

  • Develops without any prior pituitary pathology, surgery, radiation, or pharmacologic treatment of the sellar region 2
  • Results from pulsation of cerebrospinal fluid through a developmental or acquired dehiscence of the diaphragm sella 1
  • May be associated with idiopathic intracranial hypertension, particularly in patients presenting with headache and papilledema 3
  • Some evidence suggests it may represent a stage in the spontaneous course of pituitary adenomas that have undergone necrosis 4

Secondary Empty Sella

  • Occurs after treatment of pituitary tumors through neurosurgery, medications, or radiotherapy 2
  • Can develop following spontaneous necrosis (ischemia or hemorrhage) of pituitary adenomas 2
  • May result from pituitary infectious processes, autoimmune diseases, or brain trauma 2

Clinical Presentation

Asymptomatic Empty Sella

  • The majority of cases represent only a radiological finding without clinical manifestations 5, 2
  • Incidence reaches approximately 12% on neuroimaging studies and up to 35% in clinical practice 5
  • Most patients never develop symptoms and have a good prognosis with little impact on quality of life 6

Empty Sella Syndrome

  • Defined by the presence of pituitary hormonal dysfunction and/or neurological symptoms in addition to the radiographic finding 6, 2
  • Approximately 30% of patients with empty sella demonstrate some degree of hypopituitarism upon testing, though most remain asymptomatic 3, 7
  • Endocrine pituitary disorders (at least one hormone deficit) occur in 19-40% of patients 5

Key symptoms requiring urgent evaluation include: 3

  • Visual changes or visual field defects
  • Signs of hormonal deficiencies (fatigue, cold intolerance, sexual dysfunction)
  • Headache with features of increased intracranial pressure
  • CSF rhinorrhea

Diagnostic Approach

Imaging

MRI using high-resolution pituitary protocols is the gold standard for diagnosis and can confirm empty sella even without IV contrast. 1, 3, 5 The pituitary gland appears flattened with cerebrospinal fluid filling the sella turcica. 6

  • CT has limited utility and is insensitive compared to MRI for detecting pituitary pathology 3
  • Plain radiography is insensitive and nonspecific for evaluating sellar pathology 1

Mandatory Hormonal Evaluation

All patients with empty sella should undergo comprehensive hormonal screening regardless of symptoms, as hormone deficiencies may affect up to 48% of cases. 3 The hormonal panel should include:

  • Thyroid function tests (TSH, free T4) - deficiencies seen in up to 48% of cases 7
  • Morning cortisol and ACTH (adrenal axis assessment) 7
  • Sex hormones (testosterone in males, estradiol in females, FSH, LH) 7
  • Prolactin levels - elevated in approximately 28% of cases 7
  • IGF-1 for growth hormone axis evaluation 8

Management Strategy

Initial Assessment

  • Perform comprehensive hormonal screening on all patients with empty sella, even if asymptomatic 3
  • Obtain ophthalmology evaluation if visual symptoms are present or concerns about increased intracranial pressure exist 3, 6
  • Refer to endocrinology if any hormonal abnormalities are detected 3, 7

Follow-Up

  • If no alterations are detected initially, careful reevaluation at 24-36 months is suggested due to low risk of progression 5
  • Monitor for development of symptoms over time 6

Treatment of Associated Conditions

  • If associated with idiopathic intracranial hypertension, weight loss is the primary treatment, with surgical CSF diversion reserved for imminent visual loss 3
  • Hormone replacement therapy as indicated for specific deficiencies 2
  • Surgical treatment (transsphenoidal filling of the sella) is rarely indicated, primarily for progressive visual field defects or CSF rhinorrhea 9

Critical Clinical Pitfalls

Do not attribute headache directly to empty sella, as it is usually an incidental finding unrelated to headache symptoms. 3, 7 Consider more common headache etiologies first.

Do not overlook idiopathic intracranial hypertension in patients with headache and empty sella, as partially empty sella is a typical neuroimaging feature of raised intracranial pressure and represents a distinct clinical entity requiring specific management. 3

Do not skip hormonal screening even in asymptomatic patients, as affected-axis rates often exceed 10% and may reach 50%, with significant clinical implications if missed. 3

Do not order unnecessary urgent imaging or interventions in asymptomatic patients with confirmed empty sella on MRI, as this won't change immediate management. 3, 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Empty sella syndrome: Multiple endocrine disorders.

Handbook of clinical neurology, 2021

Guideline

Management of Partially Empty Sella

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The empty sella. A reappraisal of etiology and pathogenesis.

Acta neurologica Scandinavica. Supplementum, 1990

Research

Empty sella syndrome: an update.

Pituitary, 2024

Guideline

Management of Incidental Partially Empty Sella in a Patient with Headache

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Pituitary Function Tests: Recommendations and Indications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.